One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.428.428
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
 Citations: 2 |
Affiliation: University of Leeds, St James's University Hospital, Cancer Research UK Clinical Trials Unit, University of Birmingham, Cardiff and Vale University Health Board, Imperial College Healthcare NHS Trust, Beatson West of Scotland Cancer Centre, University of Oxford, Royal Liverpool and Broadgreen University Hospital NHS Trust, Barts Health NHS Trust, King's College Hospital, The Christie NHS Foundation Trust, Nottingham University Hospitals NHS Trust, University Hospital Southampton NHS Foundation TrustInitial Results of Ibrutinib Plus Venetoclax in Relapsed, Refractory CLL (Bloodwise TAP CLARITY Study): High Rates of Overall Response, Complete Remission and MRD Eradication after 6 Months of Combination Therapy
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
